Vogenx names board member Richard Gorman as chief commercial officer
VOGX•Vogenx named board member Richard “Rich” Gorman chief commercial officer, effective Oct. 12, 2026. He will leave the board and its committees, and the company plans to seek a new independent director.
1. Commercial leadership change
Gorman’s role will cover commercial operations and corporate strategy, including market development for post-bariatric hypoglycemia and gastroparesis. He has 30 years of life sciences commercial experience and has supported more than 25 launches in U.S. and international markets.
